Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's Intraday Session

Author: Benzinga Insights | July 27, 2023 01:31pm

Gainers

  • Femasys (NASDAQ:FEMY) stock rose 146.9% to $0.9 during Thursday's regular session. Femasys's stock is trading at a volume of 151.6 million shares as of 13:30 EST. This is 24201.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $13.5 million.
  • Mallinckrodt (AMEX:MNK) shares rose 30.18% to $1.64. As of 13:30 EST, Mallinckrodt's stock is trading at a volume of 75.3 million, which is 3002.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $21.6 million.
  • Cutera (NASDAQ:CUTR) shares increased by 27.74% to $18.97. As of 13:30 EST, Cutera's stock is trading at a volume of 2.6 million, which is 348.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $377.3 million.
  • Evolus (NASDAQ:EOLS) stock rose 26.93% to $9.93. Trading volume for Evolus's stock is 2.8 million as of 13:30 EST. This is 493.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $565.0 million.
  • INVO Bioscience (NASDAQ:INVO) stock moved upwards by 24.67% to $0.19. As of 13:30 EST, INVO Bioscience's stock is trading at a volume of 2.6 million, which is 191.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.1 million.
  • Talkspace (NASDAQ:TALK) shares rose 23.94% to $1.76. Trading volume for Talkspace's stock is 4.1 million as of 13:30 EST. This is 738.9% of its average full-day volume over the last 100 days. The company's market cap stands at $288.0 million. As per the press release, Q2 earnings came out today.

Losers

  • Mersana Therapeutics (NASDAQ:MRSN) stock fell 78.3% to $0.85 during Thursday's regular session. Trading volume for this security as of 13:30 EST is 142.5 million, which is 4287.0% of its average full-day volume over the last 100 days. The company's market cap stands at $97.2 million.
  • Asensus Surgical (AMEX:ASXC) shares fell 39.77% to $0.31. As of 13:30 EST, Asensus Surgical's stock is trading at a volume of 15.2 million, which is 2062.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $73.1 million.
  • Biohaven (NYSE:BHVN) stock decreased by 24.52% to $17.97. As of 13:30 EST, this security is trading at a volume of 4.3 million shares, making up 413.9% of its average full-day volume over the last 100 days. The company's market cap stands at $1.2 billion.
  • Bluejay Diagnostics (NASDAQ:BJDX) shares decreased by 22.23% to $5.53. Trading volume for Bluejay Diagnostics's stock is 125.9K as of 13:30 EST. This is 52.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.6 million.
  • Armata Pharmaceuticals (AMEX:ARMP) stock decreased by 16.79% to $2.28. Trading volume for Armata Pharmaceuticals's stock is 296.8K as of 13:30 EST. This is 237.5% of its average full-day volume over the last 100 days. The company's market cap stands at $82.4 million.
  • icad (NASDAQ:ICAD) shares declined by 16.52% to $2.83. icad's stock is trading at a volume of 770.8K shares as of 13:30 EST. This is 56.7% of its average full-day volume over the last 100 days. The company's market cap stands at $72.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ARMP ASXC BHVN BJDX CUTR EOLS FEMY ICAD INVO MNK MRSN TALK

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist